Rita M. Lysik
About
In The Last Decade
Rita M. Lysik
37 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 92
- Cancer Research 709
- Oncology 529
- Molecular Biology 328
- Hematology 326
- Immunology and Allergy 179
Countries citing papers authored by Rita M. Lysik
This map shows the geographic impact of Rita M. Lysik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita M. Lysik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita M. Lysik more than expected).
Fields of papers citing papers by Rita M. Lysik
This network shows the impact of papers produced by Rita M. Lysik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita M. Lysik. The network helps show where Rita M. Lysik may publish in the future.
Co-authorship network of co-authors of Rita M. Lysik
This figure shows the co-authorship network connecting the top 25 collaborators of Rita M. Lysik. A scholar is included among the top collaborators of Rita M. Lysik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita M. Lysik. Rita M. Lysik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 58 | |
| 2 | 35 | |
| 3 | 46 | |
| 4 | 38 | |
| 5 | 42 | |
| 6 | 78 | |
| 7 | 7 | |
| 8 | 6 | |
| 9 | 17 | |
| 10 | 44 | |
| 11 | 6 | |
| 12 | 32 | |
| 13 | 25 | |
| 14 | 18 | |
| 15 | Very low density lipoprotein hematopoiesis inhibitor from rat plasma. | 8 |
| 16 | Pharmacological studies comparing the mechanism of tumor-induced and activated macrophage-induced bone marrow cytolysis. | 3 |
| 17 | Pharmacological studies of the mechanism of tumor-induced bone marrow cytolysis. | 6 |
| 18 | Bone marrow cytolysis induced by hepatoma, teratocarcinoma, and transformed fibroblasts. | 8 |
| 19 | 35 | |
| 20 | 95 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.